How the U.K. beat the U.S. and Europe to a COVID-19 vaccine

2 December 2020 - Country’s top medicines watchdog approved a shot by Pfizer and BioNTech, as it prepares to strike out ...

Read more →

Britain becomes the first country to license a fully tested COVID-19 vaccine

1 December 2020 - Inoculations with the Pfizer-BioNTech jab could start in less than a week. ...

Read more →

UK approves Pfizer/BioNTech’s COVID-19 vaccine

2 November 2020 - The UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) has authorised Pfizer/BioNTech’s COVID-19 vaccine BNT162b2 for ...

Read more →

Innovative technology to detect abnormal heart rhythms recommended by NICE for NHS use while further data is collected

1 December 2020 - Zio ZT is the first assessment, via the NICE digital health technologies guidance development pilot project, to ...

Read more →

UK secures another two million doses of Moderna’s COVID-19 vaccine

30 November 2020 - The UK government has secured an additional two million doses of Moderna’s COVID-19 vaccine mRNA-1273, taking ...

Read more →

Will COVID-19 vaccines be cost effective—and does it matter?

26 November 2020 - The costs of other pandemic measures mean that covid-19 vaccines will probably turn out to be ...

Read more →

First jabs could take place within days in the UK

29 November 2020 - A COVID-19 vaccine could be rolled out in the UK within days, with reports approval of ...

Read more →

Merck racks up another NICE recommendation for Keytruda

25 November 2020 - That makes it number 12. ...

Read more →

NICE publishes final guidance on Nubeqa

25 November 2020 - NICE has completed its assessment of darolutamide for use in combination with androgen deprivation therapy for ...

Read more →

NICE terminates yet another appraisal of a cancer medicine

25 November 2020 - This time, the company concerned withdrew its submission. ...

Read more →

NICE backs Braftovi for BRAF positive colorectal cancer

24 November 2020 - NICE has back Pierre Fabre’s Braftovi plus cetuximab for the treatment of BRAF positive metastatic colorectal ...

Read more →

New option for people with difficult-to-treat multiple myeloma is recommended for use in Cancer Drugs Fund by NICE

24 November 2020 - Around 5,700 cases of multiple myeloma are diagnosed each year in the UK. ...

Read more →

NICE recommends another medicine for patients with multiple myeloma

18 November 2020 - Recommended for listing in the Cancer Drugs Fund. ...

Read more →

NICE is getting ready for the end of the transition period after Brexit

19 November 2020 - NICE has a key role in evaluation and access to new and innovative products for the health ...

Read more →

NICE backs Lilly’s Emgality for migraine, adding pressure on Novartis

18 November 2020 - UK cost-effectiveness agency NICE has said that Eli Lilly’s Emgality can be made available through the ...

Read more →